Source link : https://www.newshealth.biz/health-news/does-one-dme-treatment-have-edge-in-reducing-hard-exudates/
TOPLINE: Faricimab demonstrated a greater reduction in hard exudates than aflibercept in patients with diabetic macular edema (DME), according to research presented at EURETINA 2024. Hard exudates may be a useful biomarker of disease severity and treatment response, the researchers said. METHODOLOGY: Investigators analyzed data from more than 1500 patients with DME who received faricimab […]
Author : News Health
Publish date : 2024-10-03 11:25:49
Copyright for syndicated content belongs to the linked Source.